| Name | St John's Lutheran Home |
|---|---|
| Location | 3940 Rimrock Rd, Billings, Montana |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 186 |
| Occupancy Rate | 61.13% |
| Medicare ID (CCN) | 275024 |
| Legal Business Name | St Johns Lutheran Ministries Inc |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1831422658 |
| Organization Name | BILLINGS CLINIC |
| Doing Business As | ST. JOHNS LUTHERAN HOME |
| Address | 3940 Rimrock Rd, Billings, MT 59102 |
| Phone Number | 406-238-2500 |
News Archive
The coronavirus disease (COVID-19) outbreak has spread dramatically around the globe, infecting more than 92,000 people and killing more than 3,000.
Researchers from the Laboratory of Anthropology at the University of Granada have devised a new technique to determine the age of living subjects using chest and dental x-rays.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced the initiation of a Phase 3 registration clinical trial with perifosine (KRX-0401) ), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of refractory advanced colorectal cancer.
UCSF scientists have used a novel cell-based strategy to treat motor symptoms in rats with a disease designed to mimic Parkinson's disease.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The coronavirus disease (COVID-19) outbreak has spread dramatically around the globe, infecting more than 92,000 people and killing more than 3,000.
Researchers from the Laboratory of Anthropology at the University of Granada have devised a new technique to determine the age of living subjects using chest and dental x-rays.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced the initiation of a Phase 3 registration clinical trial with perifosine (KRX-0401) ), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of refractory advanced colorectal cancer.
UCSF scientists have used a novel cell-based strategy to treat motor symptoms in rats with a disease designed to mimic Parkinson's disease.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $9890 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 14.36 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 6.59 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 64.48 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 5.44 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.77 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 15.42 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 5.11 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 93.43 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 16.17 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 55.46 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.33 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 19.43 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 12.99 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 5.84 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 94.04 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 79.32 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 59.81 | 82.93 |
News Archive
The coronavirus disease (COVID-19) outbreak has spread dramatically around the globe, infecting more than 92,000 people and killing more than 3,000.
Researchers from the Laboratory of Anthropology at the University of Granada have devised a new technique to determine the age of living subjects using chest and dental x-rays.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced the initiation of a Phase 3 registration clinical trial with perifosine (KRX-0401) ), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of refractory advanced colorectal cancer.
UCSF scientists have used a novel cell-based strategy to treat motor symptoms in rats with a disease designed to mimic Parkinson's disease.
› Verified 6 days ago
Aspen Meadows Health And Rehabilitation Center Location: 3155 Ave C, Billings, Montana 59102 Phone: (406) 656-8818 |